Posted on Leave a comment

If cannabis becomes a problem: How to manage withdrawal*

Harvard Health Publishing logo

Proponents of cannabis generally dismiss the idea that there is a cannabis withdrawal syndrome. One routinely hears statements such as, “I smoked weed every day for 30 years and then just walked away from it without any problems. It’s not addictive.” Some cannabis researchers, on the other hand, describe serious withdrawal symptoms that can include aggression, anger, irritability, anxiety, insomnia, anorexia, depression, restlessness, headaches, vomiting, and abdominal pain. Given this long list of withdrawal symptoms, it’s a wonder that anyone tries to reduce or stop using cannabis. Why is there such a disconnect between researchers’ findings and the lived reality of cannabis users?*

New research highlights the problems of withdrawal, but provides an incomplete picture*

A recent meta-analysis published in JAMA cites the overall prevalence of cannabis withdrawal syndrome as 47% among “individuals with regular or dependent use of cannabinoids.” The authors of the study raise the alarm that “many professionals and members of the general public may not be aware of cannabis withdrawal, potentially leading to confusion about the benefits of cannabis to treat or self-medicate symptoms of anxiety or depressive disorders.” In other words, many patients using medical cannabis to “treat” their symptoms are merely caught up in a cycle of self-treating their cannabis withdrawal. Is it possible that almost half of cannabis consumers are actually experiencing a severe cannabis withdrawal syndrome — to the point that it is successfully masquerading as medicinal use of marijuana — and they don’t know it?*

Unfortunately, the study in JAMA doesn’t seem particularly generalizable to actual cannabis users. This study is a meta-analysis — a study which includes many studies that are deemed similar enough to lump together, in order to increase the numerical power of the study and, ideally, the strength of the conclusions. The authors included studies that go all the way back to the mid-1990s — a time when cannabis was illegal in the US, different in potency, and when there was no choice or control over strains or cannabinoid compositions, as there is now. One of the studies in the meta-analysis included “cannabis dependent inpatients” in a German psychiatric hospital in which 118 patients were being detoxified from cannabis. Another was from 1998 and is titled, “Patterns and correlates of cannabis dependence among long-term users in an Australian rural area.” It is not a great leap to surmise that Australians in the countryside smoking whatever marijuana was available to them illegally in 1998, or patients in a psychiatric hospital, might be substantively different from current American cannabis users.*

Medical cannabis use is different from recreational use*

Moreover, the JAMA study doesn’t distinguish between medical and recreational cannabis, which are actually quite different in their physiological and cognitive effects — as Harvard researcher Dr. Staci Gruber’s work tells us. Medical cannabis patients, under the guidance of a medical cannabis specialist, are buying legal, regulated cannabis from a licensed dispensary; it might be lower in THC (the psychoactive component that gives you the high) and higher in CBD (a nonintoxicating, more medicinal component), and the cannabis they end up using often results in them ingesting a lower dose of THC.*

Cannabis withdrawal symptoms are real*

All of this is not to say that there is no such thing as a cannabis withdrawal syndrome. It isn’t life-threatening or medically dangerous, but it certainly does exist. It makes absolute sense that there would be a withdrawal syndrome because, as is the case with many other medicines, if you use cannabis every day, the natural receptors by which cannabis works on the body “down-regulate,” or thin out, in response to chronic external stimulation. When the external chemical is withdrawn after prolonged use, the body is left in the lurch, and forced to rely on natural stores of these chemicals — but it takes time for the natural receptors to grow back to their baseline levels. In the meantime, the brain and the body are hungry for these chemicals, and the result is withdrawal symptoms.*

Getting support for withdrawal symptoms*

Uncomfortable withdrawal symptoms can prevent people who are dependent or addicted to cannabis from remaining abstinent. The commonly used treatments for cannabis withdrawal are either cognitive behavioral therapy or medication therapy, neither of which has been shown to be particularly effective. Common medications that have been used are dronabinol (which is synthetic THC); nabiximols (which is cannabis in a mucosal spray, so you aren’t actually treating the withdrawal); gabapentin for anxiety (which has a host of side effects); and zolpidem for the sleep disturbance (which also has a list of side effects). Some researchers are looking at CBD, the nonintoxicating component of cannabis, as a treatment for cannabis withdrawal.*

Some people get into serious trouble with cannabis, and use it addictively to avoid reality. Others depend on it to an unhealthy degree. Again, the number of people who become addicted or dependent is somewhere between the 0% that cannabis advocates believe and the 100% that cannabis opponents cite. We don’t know the actual number, because the definitions and studies have been plagued with a lack of real-world relevance that many studies about cannabis suffer from, and because the nature of both cannabis use and cannabis itself have been changing rapidly.*

How do you know if your cannabis use is a problem?*

The standard definition of cannabis use disorder is based on having at least two of 11 criteria, such as: taking more than was intended, spending a lot of time using it, craving it, having problems because of it, using it in high-risk situations, getting into trouble because of it, and having tolerance or withdrawal from discontinuation. As cannabis becomes legalized and more widely accepted, and as we understand that you can be tolerant and have physical or psychological withdrawal from many medicines without necessarily being addicted to them (such as opiates, benzodiazepines, and some antidepressants), I think this definition seems obsolete and overly inclusive. For example, if one substituted “coffee” for “cannabis,” many of the 160 million Americans who guzzle coffee on a daily basis would have “caffeine use disorder,” as evidenced by the heartburn and insomnia that I see every day as a primary care doctor. Many of the patients that psychiatrists label as having cannabis use disorder believe that they are fruitfully using cannabis to treat their medical conditions — without problems — and recoil at being labeled as having a disorder in the first place. This is perhaps a good indication that the definition doesn’t fit the disease.*

Perhaps a simpler, more colloquial definition of cannabis addiction would be more helpful in assessing your use of cannabis: persistent use despite negative consequences. If your cannabis use is harming your health, disrupting your relationships, or interfering with your job performance, it is likely time to quit or cut down drastically, and consult your doctor. As part of this process, you may need to get support or treatment if you experience uncomfortable withdrawal symptoms, which may make it significantly harder to stop using.*

* original article

**image

*** ndlr. : –.

Posted on Leave a comment

Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain

Neurospsychopharmacology
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report*

frontiers in Psychiatry
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation

Cureus logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability*

Scientific Report logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases*

British Journal of Dermatology logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Albania, once haven of illicit cannabis, set to legalise crop for medical use*

Flag of Albania

Albania plans to legalise the cultivation of cannabis for medical purposes, six years after beginning a crackdown on an illegal trade that turned it, by some accounts, into Europe’s largest outdoor grower of cannabis., reports Reuters.*

Prime Minister Edi Rama said the time was ripe for one of Europe’s poorest countries to enter the lucrative market, emulating its neighbours North Macedonia, Greece and Italy – the latter a destination of tonnes of cannabis from Albania in 2015 and 2016.*

“Illegal cultivation is completely under control,” Rama told reporters in an online news conference. “This is the third or fourth year of consolidation. We plan to pass the bill in this session of parliament.”*

Before Rama led his Socialist Party to a landslide victory in 2013, the lawless enclave of Lazarat on the Greek border had been freely cultivating cannabis on an industrial scale for a decade and a half, untouched by state intervention.*

In a massive armed operation in June 2014, police ended the town’s illicit trade. But over the next two years, cannabis cultivation spread across most of Albania, casting doubt on its resolve to fight organised crime, as the European Union – which it hopes to join – had asked.*

On Saturday, after Rama answered a question on medical cannabis at a news conference with the head of the EU delegation in Tirana, the EU mission found itself obliged to tweet that neither it nor the European Commission had anything to do with the crop.*

Albania holds a parliamentary election next year, and the idea of regularising a potential source of jobs and money could be a vote-winner.*

Koco Kokedhima, a businessman who was the first to ask for the cultivation of medicinal cannabis to be legalised, and a former Rama ally turned bitter critic, said Rama “now appears to agree with our party’s project. We hail this turnaround”.*

But Agron Duka, head of the opposition Agrarian Environmentalist Party and a former agriculture minister, said: “Anything that helps economic growth is good. But as a state we have not applied the law correctly so it can be exploited negatively.”*

In Lazarat, the villagers were asking for a full criminal amnesty for those convicted on cannabis charges if the draft was approved – not merely the amnesty for dodging tax on illicit earnings that Rama is proposing in addition to the legalisation.*

Economic analyst Mentor Nazarko said that “the income might be limited but it would help the country to a degree”, before adding: “The European Union countries are sceptical.”*

More than two dozen countries permit the use of cannabis for medical purposes, although its precise benefits, notably in reducing nausea, pain or muscle spasms, are contentious.*

* original article

**image

*** ndlr. : –.

Posted on Leave a comment

Cannabis for the treatment of dementia

Logo 86Avenue Sàrl

Sometimes there is a glimmer of hope in a world obscured by a thick web of thoughts, forgetfulness, delusions, restlessness, hallucinations, and discouragement. This paper presents recent results of scientific research concerning the relationship between dementia (including Alzheimer’s) and the human endocannabinoic system, as well as the use of cannabis as a therapeutic substance.

#NightBreeze #ExaCan #TameDementia #alzheimer



*** editor’s note. : -.


Posted on Leave a comment

Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New Zealand*

Forensic Sciences Reserach logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.